The Eargo 7 is a premium-priced OTC hearing aid ($2,550) that earned a B grade in HearAdvisor's lab testing, ranking in the top 59% of OTC devices. This invisible-in-ear design prioritizes discretion and rechargeable convenience, but our testing revealed a mixed performance profile that may not justify its top-tier price point.
In our lab testing, the Eargo 7 demonstrated above-average own-voice comfort, scoring 0.39 points better than the category average—a meaningful advantage for users sensitive to the "talking in a barrel" sensation common with hearing aids. Speech clarity in quiet environments also measured slightly above average. However, the device struggled significantly in challenging listening situations, with speech-in-noise performance falling 0.80 points below the OTC category average.
Feedback handling proved to be another weak point, measuring 0.70 points below average despite the closed sleeve coupling. This combination of below-average noise performance and feedback management may limit real-world benefit in restaurants, group conversations, and other dynamic environments.
For consumers prioritizing invisible aesthetics above all else, the Eargo 7 delivers on its core promise. However, our testing identified several OTC alternatives offering stronger sound performance at lower prices, including the Audicus Omni 2 ($1,898) and Zepp Clarity Pixie ($999). The Eargo 7 is best suited for users with mild hearing loss who primarily need help in quiet, one-on-one conversations and place high value on cosmetic discretion.
